DETROIT RECEIVING HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $173K
- Transactions
- 54
- Companies
- 21
- Average per transaction
- $3,208
Who reported the payments
| Brainscope Company, Inc. | $98,448 |
| Stryker | $18,022 |
| Smith+Nephew | $15,671 |
| Barco, Inc. | $14,740 |
| Olympus America Inc. | $6,284 |
| UCB SA | $6,110 |
| CSL Behring | $3,000 |
| Merck | $2,750 |
| Amgen | $2,630 |
| Melinta Therapeutics, LLC | $1,000 |
| Tetraphase Pharmaceuticals, Inc. | $1,000 |
| Novartis | $1,000 |
| Gilead | $1,000 |
| Convatec Inc. | $467 |
| KARL Storz Endoscopy-america | $270 |
| Fujifilm Sonosite, Inc. | $249 |
| Helena Laboratories Corporation | $232 |
| Hikma Pharmaceuticals USA | $232 |
| BD | $90 |
| Life Technologies Corporation | $22 |
| Portola Pharmaceuticals, LLC | $5 |